Biotech · Therapeutics · Innovation
Cracking Undruggable Membrane Targets
Evanti Bio's extracellular-vesicle display platform enables antibody discovery against complex membrane proteins presented in their native lipid environment.
About
Expanding the Reach of Antibody Discovery
Evanti Bio is developing a novel platform for discovering functional antibodies against complex and previously difficult-to-characterize membrane targets.
By displaying membrane proteins on extracellular vesicles, the platform is designed to preserve their native structure and biological context throughout antibody discovery.
Platform Highlights
What Sets EVAG Apart
Native presentation
Targets remain associated with a lipid bilayer, helping preserve their natural conformation.
Learn MoreComplex targets
The platform supports dynamic multipass proteins and multiprotein assemblies.
Explore PlatformDiscovery compatibility
Vesicles can be incorporated into immunization, hybridoma, B-cell screening, and phage-display workflows.
Partner With UsReady to Partner?
To discuss a target, discovery program, or strategic partnership, reach out to us directly.
Contact Us
Discuss a Discovery or Partnering Opportunity